Iconic Therapeutics
South San Francisco, US · Delaware corporation · 1 known investors
Founders & leadership
KD
Kirk DornbushExecutive
WG
William GreeneExecutive
JS
Jon SoderstromNamed on SEC filing
Board
JK
Johan KordelBoard director
BR
Bruce RobertsonBoard director
TF
Todd FoleyBoard director
PH
Peter HirthBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$79M disclosed across 4 rounds · 2014–2019
▶$13MraisedApr 2019 · 37 investors · BiotechnologyRule 506(b)
▶$13MraisedApr 2019 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce CohenDirector
- Peter HirthDirector
- Bruce RobertsonDirector
- Julia GregoryDirector
- Todd FoleyDirector
- William GreeneExecutive Officer, Director
- Kirk DornbushDirector
- Offering amount
- $16.3M
- Amount sold
- $13M
- Proceeds to insiders
- $500K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedJun 2018 · 36 investors · BiotechnologyRule 506(b)
▶$4.1MraisedJun 2018 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Julia GregoryDirector
- Kirk DornbushDirector
- Peter HirthDirector
- Bruce RobertsonDirector
- William GreeneExecutive Officer, Director
- Todd FoleyDirector
- Offering amount
- $10.9M
- Amount sold
- $4.1M
- Proceeds to insiders
- $500K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$48.6MraisedNov 2016 · 11 investors · BiotechnologyRule 506(b)
▶$48.6MraisedNov 2016 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johan KordelDirector
- Bruce RobertsonDirector
- Todd FoleyDirector
- Kirk DornbushExecutive Officer, Director
- Peter HirthDirector
- William GreeneExecutive Officer, Director
- Offering amount
- $48.6M
- Amount sold
- $48.6M
- Proceeds to insiders
- $500K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.3MraisedApr 2014 · 40 investors · BiotechnologyRule 506(b)
▶$13.3MraisedApr 2014 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kirk DornbushExecutive Officer, Director
- Todd FoleyDirector
- Bruce RobertsonDirector
- Johan KordelDirector
- William GreeneExecutive Officer, Director
- Jon SoderstromDirector
- Offering amount
- $24.3M
- Amount sold
- $13.3M
- Proceeds to insiders
- $216K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Iconic Therapeutics's investors?
- Iconic Therapeutics's investors include OUP (Osage University Partners).
- How much funding has Iconic Therapeutics raised?
- Iconic Therapeutics has disclosed $79M raised across 4 rounds.
- Where is Iconic Therapeutics headquartered?
- Iconic Therapeutics is headquartered in South San Francisco, US.